ArticleProbiotics and antimicrobial proteins2026
Development of Functional Dairy Byproducts-based Beverages Using Rutab Date and Probiotic Apilactobacillus Kunkeei EABW06.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biological and Technological Characteristics of Milk-Fermented with Probiotic Lactobacillus acidophilus La-5 and Viable/Inactivated Saccharomyces boulardii 002Y018 Cultures.Probiotics and antimicrobial proteins · 2026Article
- Bactericidal and cell membrane disruption potential of protein extract from buttermilk-derived probioticFrontiers in microbiology · 2026Article
- Freeze-Dried Probiotic Fermented Camel Milk Enriched with Ajwa Date Pulp: Evaluation of Functional Properties, Probiotic Viability, and In Vitro Antidiabetic and Anticancer Activities.Foods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was designed to valorize dairy byproducts including cheese whey and buttermilk through developing fermented beverages using a novel isolated Apilactobacillus kunkeei EABW06 strain from Egyptian bee's wax. Cheese whey or buttermilk was fermented with A. kunkeei and compared to fermented whey or buttermilk supplemented with Rutab date pulp on day one or after 15 days of cold storage. Physicochemical, microbiological, sensory, proteolytic, and various functional properties were investigated. Fermented buttermilk beverages particularly supplemented with date pulp had the highest viscosity and water-holding capacity at the beginning or after 15 days of cold storage. The supplementation with date pulp led to increase the viable count of A. kunkeei. Compared to fermented whey beverages, fermented buttermilk beverages recorded the greatest scores of sensory attributes. The proteolytic, ACE-I, and antioxidant activity enhanced in fermented buttermilk supplemented with or without date pulp. A storage period exhibited a positive effect on the proteolysis, ACE-I, and DPPH radical scavenging properties of fermented beverages. All fermented beverages showed a great inhibitory impact against the growth of various species of fungi and bacteria. Fermented buttermilk beverages demonstrated the highest cytotoxicity against Caco2 cell lines with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.